PA-1329-E1
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-03325 |
| CAS | 80860-79-3 |
| Molecular Weight | 381.39 |
| Molecular Formula | C15H23N7O5 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
PA-1329-E1 is a nucleoside antibiotic produced by Micromonospora sp. PA-1329. It exhibits activity against Candida albicans.
- Specification
- Properties
- Price Product List
| Synonyms | Antibiotic PA-1329-E1 |
| IUPAC Name | 2-amino-5-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylamino]pentanoic acid |
| Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CNCCCC(C(=O)O)N)O)O)N |
| InChI | InChI=1S/C15H23N7O5/c16-7(15(25)26)2-1-3-18-4-8-10(23)11(24)14(27-8)22-6-21-9-12(17)19-5-20-13(9)22/h5-8,10-11,14,18,23-24H,1-4,16H2,(H,25,26)(H2,17,19,20)/t7?,8-,10-,11-,14-/m1/s1 |
| InChI Key | JMMJTXDZHSZYCK-HVMNINKTSA-N |
| Appearance | White Powder |
| Melting Point | 167-170°C |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-00586 | Brefeldin A | Inquiry |
| BBF-05818 | Docosahexaenoic acid | Inquiry |
| BBF-05877 | Coenzyme Q10 | Inquiry |
| BBF-03963 | Pristinamycin | Inquiry |
| BBF-03428 | Tubermycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
